Aberrant expression of upstream regulators, such as mTOR (mammalian target of rapamycin) and eIF4E (eukaryotic translation initiation factor 4E), has been linked to the development of aggressive breast cancer phenotypes, further emphasizing the significance of investigating protein synthesis pathways in breast cancer [129, 130]. The gene discussed is MTOR; the disease is breast carcinoma.